Coforge Gears Up for Q2 Reveal on 24th October; Check Key Expectations Here

Name: Stock Advisory service In India
Brand: univest
Rating: 4.4 (197000 reviews)

Posted by : sachet | Thu Oct 16 2025

Coforge Gears Up for Q2 Reveal on 24th October; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q2 Results

Coforge Q2 Results: Coforge, a bulk drug manufacturer serving various pharmaceutical companies, is all set to announce its Q2 results for FY26 on 24th October 2025. Financial analysts anticipate an increase in revenue due to higher sales and significant growth in PAT.

Table of Contents

Coforge Q2 Results 2025 Preview

Coforge’s revenue is expected to be in the range of ₹3,062.30 crore to ₹4,678.56 crore, marking a healthy 29.92% to 30.00% YoY increase.
Profit After Tax, or PAT, is projected to rise by 51.80% YoY or 34.67% QoQ.
EBITDA of Coforge is expected to decrease by 36.72% YoY to ₹3,567.00 crore.
Gross profit is expected to increase by 21.20% (QoQ) and 25.80% (YoY).

Coforge Share Performance

In the past six months, the share price of Coforge has risen by 37.51% to reach ₹1,762.50.
Moreover, over the past year, the stock has risen by 22.32%.
Despite this weak short-term performance, Coforge’s stock has delivered a financially sound return of 2.81% over the past 5 years.
As of 16th October 2025, the stock traded at ₹1,762.60 per share, with a day high of ₹1,775.00.

Key Factors to Watch for Coforge

Coforge operates in a highly competitive market, facing pressure from both domestic and international brands.
The company’s in-house manufacturing capabilities enable better quality control and strategic operations.
Coforge’s performance is mainly linked to the broader economic cycle, and high inflation can reduce demand for its products.

Final Thoughts

Coforge will announce its Q2 FY26 results on 24th October, 2025. Analysts expect strong revenue growth of up to 29.92% YoY, a 51.80% rise in PAT, and a 51.08% increase in EBITDA. Coforge mainly focuses on the new products of this company and EBITDA growth.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!